SCHEMBL3170421

SCHEMBL3170421

CC(=O)NCCNc1cc(NC(=O)CN2CCN(c3ccc(C(C)=O)cc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ ALDH1A1 P00352 6/20 0.49
▸ EGFR P00533 2/20 0.48
▸ KDM4E B2RXH2 2/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ TSHR P16473 4/20 0.46
▸ GAA P10253 2/20 0.45
▸ USP2 O75604 2/20 0.45
▸ HTT P42858 1/20 0.44
▸ JAK2 O60674 1/20 0.44
▸ JAK3 P52333 1/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ ATM Q13315 1/20 0.44
▸ ME2 P23368 1/20 0.43
▸ ME1 P48163 1/20 0.43
▸ ME3 Q16798 1/20 0.43
▸ REV1 Q9UBZ9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162425 0.95 EGFR (0.53) SMN1; SMN2ALDH1A1EGFRKDM4ETSHR
SCHEMBL3166249 0.93 GAA (0.54) SMN1; SMN2ALDH1A1EGFRKDM4ETSHR
SCHEMBL3161698 0.92 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1EGFRGAAUSP2
SCHEMBL3162806 0.92 JAK3 (0.51) SMN1; SMN2ALDH1A1EGFRTSHRGAA
SCHEMBL3175543 0.91 EGFR (0.50) SMN1; SMN2ALDH1A1EGFRKDM4ETSHR
SCHEMBL3165286 0.91 USP2 (0.57) SMN1; SMN2ALDH1A1KDM4ETSHRUSP2
SCHEMBL3258722 0.90 EGFR (0.46) SMN1; SMN2ALDH1A1EGFRKDM4ETSHR
SCHEMBL3166342 0.89 ALDH1A1 (0.57) SMN1; SMN2ALDH1A1EGFRKDM4ETSHR
SCHEMBL3164831 0.88 MAPT (0.50) SMN1; SMN2ALDH1A1EGFRKDM4ETDP1
SCHEMBL3160939 0.88 ALDH1A1 (0.52) SMN1; SMN2ALDH1A1EGFRKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback